BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26745376)

  • 21. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.
    Pollara J; Jones DI; Huffman T; Edwards RW; Dennis M; Li SH; Jha S; Goodman D; Kumar A; LaBranche CC; Montefiori DC; Fouda GG; Hope TJ; Tomaras GD; Staats HF; Ferrari G; Permar SR
    J Virol; 2019 May; 93(10):. PubMed ID: 30842326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
    Front Immunol; 2018; 9():244. PubMed ID: 29651286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission.
    Parsons MS; Madhavi V; Ana-Sosa-Batiz F; Center RJ; Wilson KM; Bunupuradah T; Ruxrungtham K; Kent SJ
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):17-23. PubMed ID: 26761269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of NK cells by ADCC responses during early HIV infection.
    Chung AW; Navis M; Isitman G; Centre R; Finlayson R; Bloch M; Gelgor L; Kelleher A; Kent SJ; Stratov I
    Viral Immunol; 2011 Apr; 24(2):171-5. PubMed ID: 21449728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.
    Isitman G; Lisovsky I; Tremblay-McLean A; Kovacs C; Harris M; Routy JP; Bruneau J; Wainberg MA; Tremblay C; Bernard NF
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1079-1088. PubMed ID: 27499379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    Tomescu C; Tebas P; Montaner LJ
    AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1.
    Tay MZ; Kunz EL; Deal A; Zhang L; Seaton KE; Rountree W; Eudailey JA; Heptinstall J; McRaven MD; Matias E; McGuire E; Yates NL; Perez LG; Montefiori DC; Overman RG; Hope TJ; Shen X; Kalilani L; Fouda GG; Tomaras GD; Permar SR
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
    Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
    Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ
    J Infect Dis; 2015 Feb; 211(4):529-38. PubMed ID: 25170105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway.
    Mielke D; Bandawe G; Pollara J; Abrahams MR; Nyanhete T; Moore PL; Thebus R; Yates NL; Kappes JC; Ochsenbauer C; Garrett N; Abdool Karim S; Tomaras GD; Montefiori D; Morris L; Ferrari G; Williamson C
    Front Immunol; 2019; 10():2875. PubMed ID: 31921139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficient IL-2 Produced by Activated CD56
    Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
    Front Immunol; 2019; 10():1647. PubMed ID: 31379845
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.
    Mayr LM; Decoville T; Schmidt S; Laumond G; Klingler J; Ducloy C; Bahram S; Zolla-Pazner S; Moog C
    Sci Rep; 2017 Oct; 7(1):12655. PubMed ID: 28978939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.
    Ruiz MJ; Ghiglione Y; Falivene J; Laufer N; Holgado MP; Socías ME; Cahn P; Sued O; Giavedoni L; Salomón H; Gherardi MM; Rodríguez AM; Turk G
    J Virol; 2016 Jan; 90(2):670-81. PubMed ID: 26491172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?
    Lee WS; Kent SJ
    Curr Opin HIV AIDS; 2018 Mar; 13(2):160-166. PubMed ID: 29194123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
    Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
    Front Immunol; 2018; 9():3163. PubMed ID: 30697215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.
    Forthal DN; Landucci G; Daar ES
    J Virol; 2001 Aug; 75(15):6953-61. PubMed ID: 11435575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.
    Su B; Dispinseri S; Iannone V; Zhang T; Wu H; Carapito R; Bahram S; Scarlatti G; Moog C
    Front Immunol; 2019; 10():2968. PubMed ID: 31921207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid degranulation of NK cells following activation by HIV-specific antibodies.
    Chung AW; Rollman E; Center RJ; Kent SJ; Stratov I
    J Immunol; 2009 Jan; 182(2):1202-10. PubMed ID: 19124764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.